Chemkart India Share Price
185.05+4.05 (+2.24%)
-7.47% past 1 Year
Chemkart India is a one stop destination for various nutritional, Health and sports supplement products, which are largely biased towards the food products providing health benefits in addition to their
Corporate filings & documents
Announcements
Revised Annual Report 2025-26. (Rectified post Typographical errors).
1 day agoRevised Annual Report 2025-26. (Rectified post Typographical errors).
1 day agoCopies of Newspaper Publications dated 27th August 2026.
1 week agoCopies of Newspaper Publications dated 27th August 2026.
1 week agoAnnual Report for the Financial Year 2025-26.
1 week agoAnnual Report for the Financial Year 2025-26.
1 week agoE-Voting Information for 7th AGM.
1 week agoE-Voting Information for 7th AGM.
1 week agoNotice of 7th AGM to be held on 19th September 2026.
1 week agoNotice of 7th AGM to be held on 19th September 2026.
1 week agoCopies of Newspaper Publications related to 7th AGM of the Company.
2 weeks agoCopies of Newspaper Publications related to 7th AGM of the Company.
2 weeks agoAppointment of Secretarial Auditor for 5 Years subject to Shareholders Approval.
2 weeks agoAppointment of Secretarial Auditor for 5 Years subject to Shareholders Approval.
2 weeks agoAppointment of Statutory Auditors for 5 Years subject to Shareholders Approval.
2 weeks agoAppointment of Statutory Auditors for 5 Years subject to Shareholders Approval.
2 weeks agoOutcome of Board Meeting dated 18th August 2026.
2 weeks agoOutcome of Board Meeting dated 18th August 2026.
2 weeks agoWe are submitting Monitoring Agency Report for the Quarter ended 30th June 2026.
2 weeks agoWe are submitting Monitoring Agency Report for the Quarter ended 30th June 2026.
2 weeks agoDisclosure under Regulation 30 of SEBI LOD Regulations 2015 for Acqusition of Equity Shares in Wholly-Owned Subsidiary Company.
3 weeks agoDisclosure under Regulation 30 of SEBI LOD Regulations 2015 for Acqusition of Equity Shares in Wholly-Owned Subsidiary Company.
3 weeks agoDisclosure under Regulation 74(5) for Quarter ended 30th June 2026.
1 month agoDisclosure under Regulation 74(5) for Quarter ended 30th June 2026.
1 month agoCopy of Press Release issued by the Company.
1 month agoCopy of Press Release issued by the Company.
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jaini Mehta
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jaini Mehta
1 month agoPursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulation 2015 we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company
1 month agoPursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulation 2015 we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shailesh Mehta
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shailesh Mehta
1 month agoPursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015 we are submitting herewith the revised disclosures received to the Company under Reg 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company
2 months agoPursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015 we are submitting herewith the revised disclosures received to the Company under Reg 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company
2 months agoPursuant to Reg 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015 we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company.
2 months agoPursuant to Reg 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015 we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company.
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shailesh Vinodrai Mehta
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shailesh Vinodrai Mehta
2 months agoPursuant to Reg 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015 we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company.
2 months agoPursuant to Reg 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015 we are submitting herewith the disclosures received to the Company under Reg 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company.
2 months agoDisclosure under Regulation 30 for Investment in Wholly Owned Subsidiary Company.
2 months agoDisclosure under Regulation 30 for Investment in Wholly Owned Subsidiary Company.
2 months agoPursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015 we are submitting herewith the disclosures received to the Company under Regulation 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company.
2 months agoPursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations 2015 we are submitting herewith the disclosures received to the Company under Regulation 7(2)(a) of PIT Regulations from Designated Person(s) of the Company in respect to the Acquisition of Equity Shares of the Company.
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jaini Shailesh Mehta
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jaini Shailesh Mehta
2 months agoDisclosure of Acquistion of Equity Shares in Wholly Owned Subsidiary Company by way of Rights Issue.
2 months agoDisclosure of Acquistion of Equity Shares in Wholly Owned Subsidiary Company by way of Rights Issue.
2 months agoInvestors Presentation based on Financial Results for the Half Year and the Financial Year ended 31st March 2026.
3 months agoInvestors Presentation based on Financial Results for the Half Year and the Financial Year ended 31st March 2026.
3 months agoAnnual reports
Concalls & investor presentations
May 2026
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Office No. 403/404, 4th Floor K. L. Accolade, 6th Road Tps I I I, Santacruz (East) Mumbai Maharashtra PIN: 400055 Tel No: 9136383828 Fax No: NULL Email: [email protected] Internet: https://chemkart.com/
Registrars
Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093(old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059Tel: + 91 21 626 38200Fax: Office No S6-2, 6th Floor, Pinnacle Business Park Next to Ahura Centre, Mahakali Caves Road Andheri (E) PIN: Tel No: 91-022-62638200 Fax No: 91-022-62638299 Email: [email protected]
Management
Ankit Shailesh Mehta, Chairman & Managing Director
Ankit Shailesh Mehta, Chairman & Managing Director
Parul Shailesh Mehta, Executive Director
Shailesh Vinodrai Mehta, Executive Director
Rajesh Kalro, Non Executive Independent Director
Anirudh Ruia, Non Executive Independent Director
Abhishek Kamdar, Non Executive Independent Director
Shreya Dalmia, Company Secretary & Compliance Officer
Details
BSE 544442
NSE NULL
ISIN INE0VWL01017